Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure

• Published in: American journal of respiratory and critical care medicine 2021-05, Vol.203 (10), p.1257-1265
• Main Authors: Alladina, Jehan, Levy, Sean D, Cho, Josalyn L, Brait, Kelsey L, Rao, Sowmya R, Camacho, Alexander, Hibbert, Kathryn A, Harris, R Scott, Medoff, Benjamin D, Januzzi, James L, Thompson, B Taylor, Bajwa, Ednan K
• Format: Article
• Language: English
• Subjects: Adult; Aged; Airway Extubation; Biomarkers; Biomarkers - blood; Female; Hospital Mortality; Humans; Interleukin-1 Receptor-Like 1 Protein - blood; Interleukin-6 - blood; Lung diseases; Male; Middle Aged; Odds Ratio; Original; Patient Selection; Plasma; Respiratory distress syndrome; Respiratory failure; Respiratory Insufficiency - blood; Respiratory Insufficiency - mortality; Respiratory Insufficiency - therapy; Time Factors; Ventilator Weaning; Ventilators
• ISSN: 1073-449X; 1535-4970
• DOI: 10.1164/rccm.202005-1951OC

Standard physiologic assessments of extubation readiness in patients with acute hypoxemic respiratory failure (AHRF) may not reflect lung injury resolution and could adversely affect clinical decision-making and patient outcomes. We hypothesized that elevations in inflammatory plasma biomarkers sST2 (soluble suppression of tumorigenicity-2) and IL-6 indicate ongoing lung injury in AHRF and better inform patient outcomes compared with standard clinical assessments. We measured daily plasma biomarkers and physiologic variables in 200 patients with AHRF for up to 9 days after intubation. We tested the associations of baseline values with the primary outcome of unassisted breathing at Day 29. We analyzed the ability of serial biomarker measurements to inform successful ventilator liberation. Baseline sST2 concentrations were higher in patients dead or mechanically ventilated versus breathing unassisted at Day 29 (491.7 ng/ml [interquartile range (IQR), 294.5-670.1 ng/ml] vs. 314.4 ng/ml [IQR, 127.5-550.1 ng/ml];  = 0.0003). Higher sST2 concentrations over time were associated with a decreased probability of ventilator liberation (hazard ratio, 0.80 per log-unit increase; 95% confidence interval [CI], 0.75-0.83;  = 0.03). Patients with higher sST2 concentrations on the day of liberation were more likely to fail liberation compared with patients who remained successfully liberated (320.9 ng/ml [IQR, 181.1- 495.6 ng/ml] vs. 161.6 ng/ml [IQR, 95.8-292.5 ng/ml];    0.002). Elevated sST2 concentrations on the day of liberation decreased the odds of successful liberation when adjusted for standard physiologic parameters (odds ratio, 0.325; 95% CI, 0.119-0.885;    0.03). IL-6 concentrations did not associate with outcomes. Using sST2 concentrations to guide ventilator management may more accurately reflect underlying lung injury and outperform traditional measures of readiness for ventilator liberation.